Granahan Investment Management Q3 2022 holdings

$3.06 Billion is the total value of Granahan Investment Management's 176 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 100.0% .

 Value Shares↓ Weighting
RNLX ExitRENALYTIX PLCads$0-324,199
-100.0%
-0.03%
SMLR ExitSEMLER SCIENTIFIC INC$0-28,099
-100.0%
-0.03%
CNMD ExitCONMED CORP$0-8,751
-100.0%
-0.03%
SMED ExitSHARPS COMPLIANCE CORP$0-471,437
-100.0%
-0.05%
CCXI ExitCHEMOCENTRYX INC$0-168,245
-100.0%
-0.14%
AERI ExitAERIE PHARMACEUTICALS INC$0-707,398
-100.0%
-0.18%
RVLV ExitREVOLVE GROUP INCcl a$0-212,240
-100.0%
-0.19%
SWIR ExitSIERRA WIRELESS INC$0-484,711
-100.0%
-0.39%
BFAM ExitBRIGHT HORIZONS FAM SOL IN D$0-321,208
-100.0%
-0.93%

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Destra Capital Advisors LLC #1

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • Susan Rawley — VP/Operations and Account Administration

Compare quarterly holdings

Export Granahan Investment Management's holdings

EDGAR filings